[
  {
    "nct_id": "NCT12345678",
    "title": "Study of Novel Therapy in Breast Cancer",
    "conditions": [
      "Breast Cancer",
      "Metastatic Breast Cancer"
    ],
    "inclusion_criteria": "Age >= 18 years, ECOG performance status 0-2, Hemoglobin >= 10 g/dL, HER2 positive",
    "exclusion_criteria": "Pregnant women, History of heart disease, Active infection",
    "study_type": "Interventional",
    "phase": "Phase 2",
    "enrollment": "100",
    "sponsor": "Sample Pharma Inc."
  },
  {
    "nct_id": "NCT87654321",
    "title": "Lung Cancer Treatment Study",
    "conditions": [
      "Lung Cancer",
      "Non-Small Cell Lung Cancer"
    ],
    "inclusion_criteria": "Age >= 18 years, ECOG 0-1, Platelets >= 100,000/\u03bcL, EGFR mutation positive",
    "exclusion_criteria": "Diabetes mellitus, HIV positive, Previous chemotherapy",
    "study_type": "Interventional",
    "phase": "Phase 3",
    "enrollment": "200",
    "sponsor": "Research Institute"
  }
]